BLRX News and Press, BioLineRx Ltd.

2024-05-30 13:54:38 ET More on biolinerx BioLineRx Ltd. (BLRX) Q1 2024 Earnings Call Transcript BioLineRx Ltd. (BLRX) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on biolinerx Historical earnings data for biolinerx Financial in...

BioLineRx Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell (HSC) Mobilization For Gene Therapy Applications in Sickle Cell Disease (SCD) PR Newswire - Investigator-initiated study in...

2024-05-28 17:56:01 ET BioLineRx Ltd. (BLRX) Q1 2024 Earnings Call Transcript May 28, 2024, 08:30 AM ET Company Participants John Lacey - Head of IR and Corporate Communications Phil Serlin - CEO Holly May - President of BioLineRx USA Mali Zeevi - CFO C...

2024-05-28 07:03:56 ET More on biolinerx Seeking Alpha’s Quant Rating on biolinerx Historical earnings data for biolinerx Financial information for biolinerx Read the full article on Seeking Alpha For further details see: biolinerx GAAP EPS...

Orkla ASA ADR (ORKLY) is expected to report for Q1 2024 Cosmos Health Inc. (COSM) is expected to report $-0.14 for Q1 2024 Basilea Pharmaceutica AG Registered Shares (BPMUF) is expected to report for Q1 2024 DCC Plc (DCCPF) is expected to report for Q4 2024 Datatec Ltd ADR (DTTLY)...

2024-05-26 08:00:00 ET More on related stocks: After Doubling, A Downgrade For DICK'S Sporting Goods Is Prudent Salesforce: A Strong Buy Before Q1 Earnings Digital Turbine Q4 Earnings Preview: Potential Inflection Point Gap expected to surprise Wall Street wi...

2024-05-24 13:44:12 ET More on biolinerx BioLineRx Ltd. (BLRX) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on biolinerx Historical earnings data for biolinerx Financial information for biolinerx Read the full article on Seek...

BioLineRx Announces Abstract on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating Motixafortide in First-Line Pancreatic Cancer (PDAC) at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting PR Newswire New analysis of biopsy samples demonstrate...

Yoshiharu Global Co. (YOSH) is expected to report for Q1 2024 Analog Devices Inc. (ADI) is expected to report $1.26 for Q2 2024 Simplicity Esports (WINR) is expected to report for Q3 2024 Klepierre (KLPEF) is expected to report for Q1 2024 Synopsys Inc. (SNPS) is expected to repor...

BioLineRx to Report First Quarter 2024 Results on May 28, 2024 PR Newswire Management to Hold Conference Call at 8:30 a.m. EDT TEL AVIV, Israel , May 22, 2024 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceut...